The effect of varenicline on depression in smokers

Phase 2

• Conditions: major depressive disorder.; Major depressive disorder, single episode

• Registration Number: IRCT20190308042972N1
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Persons in ranged 18 to 60 years old
Smokers under methadone maintenance therapy
Patients with Major depressive disorder

Exclusion Criteria

The patient's desire to withdraw from the study
Create a noticeable and persistent drug problem
Have a systemic disease
Patients with substance use (Based on Self-report)
Patients with psychotic disorder
Patients with suicidal thoughts
The patients under treatment with psychiatric drugs
Depression is follow to substance use
Depression is associated with medical illness
The patient is taking drugs that cause depression

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression Score. Timepoint: First, 3 weeks later, 6 weeks later. Method of measurement: Beck Depression Inventory(I-II).